资本眼 一周行情 11月3日至11月7日，医药生物指数下跌2.62%，跑输上证指数2.37个百分点，连续七周跑输上证指数。创新药（BK1106）周内下跌3.51%；恒生医疗保健业指数（HSCICH）周下跌2.39%；港股创新药ETF（513120）周内下跌3.92%。 一周点评 经历一轮强劲上涨后，创新药行业已步入挤泡沫阶段。投资重回理性，对行业来说不是坏事，但在一定程度上，当前市场调整...
Source Link资本眼 一周行情 11月3日至11月7日，医药生物指数下跌2.62%，跑输上证指数2.37个百分点，连续七周跑输上证指数。创新药（BK1106）周内下跌3.51%；恒生医疗保健业指数（HSCICH）周下跌2.39%；港股创新药ETF（513120）周内下跌3.92%。 一周点评 经历一轮强劲上涨后，创新药行业已步入挤泡沫阶段。投资重回理性，对行业来说不是坏事，但在一定程度上，当前市场调整...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.